Olema Pharmaceuticals (OLMA) Announces $180M in New Financing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Olema Oncology Announces Combined Financing for Up to $180 Million
September 5, 2023 7:30 AM EDT$130 million equity private placement led by Paradigm BioCapital with participation by Lightspeed Venture Partners, Deep Track Capital, BVF Partners L.P., Cormorant Asset Management, Vivo Capital, Logos Capital, and Woodline Partners LP
Senior secured credit facility for up to $50 million provided by Silicon Valley Bank
Financing provides sufficient capital to fund Olema beyond OPERA-01 clinical trial top-line data and into 2027
SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) --... More
